Recent Finacing
Recent Raise
ACT Genomics is a Taiwan-based cancer molecular diagnostics company that provides NGS-based comprehensive genomic profiling (ACTOnco®+), ctDNA monitoring, bioinformatics reporting, and clinical services from a CAP-accredited lab across Asia.
